Publications
Viruses
An Endogenous Retrovirus Vaccine Encoding an Envelope with a Mutated Immunosuppressive Domain in Combination with Anti-PD1 Treatment Eradicates Established Tumours in Mice Viruses.
April 6, 2023
Daradoumis J, Ragonnaud E, Skandorff I, Nielsen KN, Bermejo AV, Andersson AM, Schroedel S, Thirion C, Neukirch L, Holst PJ
Cancer Immunology Research
Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome-Positive C3 Cancers in Mice. Cancer Immunol Res.
February 3, 2023
International Journal of Molecular Sciences
Immunogenicity of Human Endogenous Retroviral Proteins in Cancer and Discussion of Therapeutic Approaches.
January 25, 2022
Vaccines (Basel)
Novel Antigenic Targets of HPV Therapeutic Vaccines. Vaccines (Basel)
November 1, 2021
Boilesen DR, Nielsen KN, Holst PJ.
Frontiers in Immunology
Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPs. Front Immunol.
October 28, 2021
Neckermann P, Boilesen DR, Willert T, Pertl C, Schrödel S, Thirion C, Asbach
Science Translational Medicine
MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans
June 17, 2020
Esposito I, Cicconi P, D’Alise AM, et al.
Expert Review of Vaccines
The potential of adenoviral vaccine vectors with altered antigen presentation capabilities. Expert Rev Vaccines
January 2020
Neukirch L, Fougeroux C, Andersson AC, Holst PJ.
International Journal of Molecular Sciences
Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy.
2020
Bermejo AV, Ragonnaud E, Daradoumis J, Holst PJ.
Oncotarget
Adenovirus-Based Virus-Like-Vaccines Targeting Endogenous Retroviruses Can Eliminate Growing Colorectal Cancers in Mice.
2019
Neukirch L, Nielsen TK, Laursen H, Daradoumis J, Thirion C, Holst PJ.
Vaccine
Replication Deficient Human Adenovirus Vector Serotype 19a/64: Immunogenicity in Mice and Female Cynomolgus Macaques
2018
Ragonnaud E, Schroedel S, Mariya S, Iskandriati D, Pamungkas J, Fougeroux C, Daradoumis J, Thomsen A. R., Neukirch L, Ruzsics Z, Salomon M, Thirion C, Holst PJ.
Vaccines
Virus-Like-Vaccines Against HIV
2018
Andersson A. M. C., Schwerdtfeger M., Holst P. J.
EBioMedicine
Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.
2017
Xu H., Andersson A. M., Ragonnaud E., Boilesen D., Tolver A., Jensen B. A. H., Blanchard J. L., Nicosia A., Folgori A., Colloca S., Cortese R., Thomsen A. R., Christensen J. P., Veazey R. S., Holst P. J.
Vaccine
Novel Adenovirus Encoded Virus-Like Particles Displaying the Placental Malaria Associated VAR2CSA Antigen.
2017
Andersson A. M. C., Resende M., Salanti A., Nielsen M. A., Holst P. J.
Journal of Immunotherapy
Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix.
2017
Ragonnaud E., Andersson A. M. C., Mariya S., Pedersen A. G., Burk R. D., Folgori A., Colloca S., Cortese R., Nicosia A., Pamungkas J., Iskandriati D., Holst P. J.
Journal of Translational Medicine
Increased T Cell Breadth and Antibody Response Elicited in Prime-Boost Regimen by Viral Vector Encoded Homologous SIV Gag/Env in Outbred CD1 Mice.
2016
Andersson A. M. C., Holst P. J.
Vaccine
Effect of HIV-1 Envelope Cytoplasmic Tail on Adenovirus Primed Virus-Encoded Virus-Like Particle Immunizations.
2016
Xu H., Andersson A. M. C., Ragonnaud E., Seaton K. E., Sawant S., Folgori A., Colloca S., Labranche S., Montefiori D. C., Tomaras G. D., Holst P. J.
Molecular Cancer Research
Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.
September 2016
Clausen T. M., Pereira M. A., Nakouzi N. A., Oo H. Z., Agerbæk M. Ø., Lee S., Ørum-Madsen M. S., Kristensen A. R., El-Naggerm A., Grandgenett P. M., Grem J. L., Hollingsworth M. A., Holst P. J., Theander T., Sorensen P. H., Daugaard M., Salanti A.
